Sign in

You're signed outSign in or to get full access.

Matthew Thornton III

About Matthew Thornton III

Matthew Thornton III (born 1958) is an Independent Board Member of Nuveen Mortgage & Income Fund (JLS) with over 40 years of operating leadership experience at FedEx, including EVP & COO of FedEx Freight (2018–2019) and SVP, U.S. Operations at FedEx Express (2006–2018). He holds a B.B.A. from the University of Memphis (1980) and an M.B.A. from the University of Tennessee (2001), and joined the Nuveen fund boards in 2020 with a current Class III term running until the 2027 annual meeting. He currently serves on public company boards at The Sherwin-Williams Company (Audit; Nominating & Corporate Governance) and Crown Castle International (Strategy; Compensation), and is a member of the Executive Leadership Council and NACD with prior recognitions by Black Enterprise (2017) and Ebony (2016).

Past Roles

OrganizationRoleTenureCommittees/Impact
FedEx Freight Corporation (FedEx)Executive Vice President & Chief Operating Officer2018–2019Responsible for day-to-day operations, strategic guidance, modernization of freight ops, customer solutions.
Federal Express Corporation (FedEx Express)Senior Vice President, U.S. Operations2006–2018Led U.S. operations; prior roles included various FedEx management positions.
FedEx (various subsidiaries)Management roles of increasing responsibilityPre-2006Progressive operating leadership experience.

External Roles

OrganizationRoleSinceCommittees/Notes
The Sherwin-Williams CompanyDirector2014Member: Audit; Nominating & Corporate Governance.
Crown Castle InternationalDirector2020Member: Strategy; Compensation.
Safe Kids Worldwide (non-profit)Director (former)2012–2018Board service focused on injury prevention.
Executive Leadership Council (ELC)Member2014–presentSenior executive leadership network.
National Association of Corporate Directors (NACD)Membern/aGovernance professional association.

Board Governance

Governance ElementDetails
IndependenceAll nominees and current/continuing Board Members, including Thornton, are not “interested persons” under the 1940 Act and are deemed Independent Board Members.
Board Class/TermClass III; term runs until the 2027 annual shareholder meeting; service since 2020.
Committee Memberships (JLS complex)Audit Committee – Member; not designated an “audit committee financial expert” (experts are Moschner, Nelson, Starr, Young).
Dividend Committee – Chair.
Nominating & Governance Committee – Member.
Investment Committee – Member.
Closed-End Fund Committee – Member.
Compliance, Risk Management & Regulatory Oversight – Not listed as a member.
AttendanceEach Board Member attended 75% or more of Board and applicable committee meetings during the last fiscal year.

JLS (Nuveen Mortgage & Income Fund) Meeting Load (FY last ended Dec 31, 2024)

Meeting TypeCount
Regular Board5
Special Board9
Executive Committee5
Dividend Committee10
Audit Committee14
Nominating & Governance5
Investment Committee4
Closed-End Fund Committee4
Compliance, Risk Mgmt & Regulatory Oversight5

Fixed Compensation

Compensation structure transitioned in 2024 from meeting-fee centric to retainer-centric, with further increases effective January 1, 2025. Amounts below are for Independent Board Members; actual allocation is spread across the Nuveen fund complex.

Component2023 (pre-2024)20242025
Annual Board Retainer$210,000 $350,000 $350,000
Audit Committee – Member Retainer$2,500 per meeting $30,000 $35,000
Investment Committee – Member Retainer$2,500 per meeting $20,000 $30,000
Dividend Committee – Member Retainer$1,250 per meeting $20,000 $25,000
Nominating & Governance – Member Retainer$500 per meeting $20,000 $25,000
Closed-End Fund Committee – Member Retainer$2,500 per meeting (listed among committees at this rate) $20,000 $25,000
Dividend Committee – Chair Fee$20,000 $20,000 $25,000
Ad hoc/Special Assignment Fees$5,000/day for site visits (2023); ad hoc meeting fees $1,000–$2,500; special assignment chairs/members quarterly fees from $1,250/$5,000 (2024+)
Board/Committee Chair (reference)Board Chair $140,000 (2023); $150,000 (2025); Audit/Compliance Chairs $30,000 (2024) → $35,000 (2025); Investment Chair $20,000 (2024) → $30,000 (2025)

Note: Retainers/fees are allocated among the Nuveen funds; in some cases, fees are allocated only to funds discussed at a given meeting. Deferred compensation elections are available via the Nuveen funds Deferred Compensation Plan.

Performance Compensation

ElementDisclosure for Directors
Target/Actual BonusNot applicable for Independent Board Members; compensation described consists of retainers/fees.
Equity Awards (RSUs/PSUs/Options)No director equity award program disclosed in the proxy for fund directors.
Performance MetricsNo performance-based compensation metrics (e.g., TSR/EBITDA) disclosed for fund directors.
Clawback/COC/SeveranceNot applicable to Independent Board Members in the proxy; no such provisions disclosed for directors.

Other Directorships & Interlocks

CompanyRoleCommitteesPotential Interlock/Conflict Notes
The Sherwin-Williams CompanyDirectorAudit; Nominating & Corporate GovernanceExternal public issuer; no related-party transactions with Nuveen funds disclosed.
Crown Castle InternationalDirectorStrategy; CompensationExternal public issuer; no related-party transactions with Nuveen funds disclosed.

Expertise & Qualifications

  • Deep operating background in logistics/transportation with FedEx senior leadership roles.
  • Public company governance experience on Audit, Compensation, Strategy, and Nominating & Corporate Governance committees (SW; Crown Castle).
  • Education: B.B.A. (University of Memphis, 1980); M.B.A. (University of Tennessee, 2001).
  • Professional affiliations: Executive Leadership Council (since 2014); NACD member; recognized by Black Enterprise (2017) and Ebony (2016).

Equity Ownership

MeasureJLS (Mortgage & Income)
Dollar range beneficially owned (as of Dec 31, 2024)$0
Ownership as % of shares outstanding<1% (individual beneficial holdings of each Board Member)
Shares pledged/hedgedNo pledging/hedging disclosures for directors identified in proxy.
Fund shares outstanding (for context)5,476,626 common shares as of Feb 18, 2025.

Note: Thornton holds “Over $100,000” in a different Nuveen fund (Floating Rate Income), but $0 in JLS as of the disclosed date.

Governance Assessment

  • Strengths
    • Broad operating expertise and multi-committee engagement, including as Chair of the Dividend Committee and member of Audit, Investment, Nominating & Governance, and Closed-End Fund Committees, supports board effectiveness in oversight of distributions, financial reporting, investment risk, and discount management.
    • Independent status with at least 75% attendance across Board and committee meetings enhances investor confidence in oversight rigor.
    • External public board experience on key oversight committees (Audit/NomGov at Sherwin-Williams; Strategy/Compensation at Crown Castle) adds cross-industry governance perspective.
  • Watch items / potential concerns
    • JLS-specific ownership is $0 as of the latest disclosure, which may be perceived as weaker “skin-in-the-game” alignment relative to JLS shareholders, though he has material holdings in another Nuveen fund.
    • Not designated as an “audit committee financial expert” (while serving on the Audit Committee), though the committee includes multiple designated experts.
  • Process/structure observations
    • The 2024–2025 shift to larger retainers and standardized committee retainers (vs. per-meeting fees) indicates increased emphasis on standing oversight responsibilities and predictable workload across the fund complex.
    • No related-party transactions or Section 16(a) delinquencies disclosed; independent auditor relationships overseen by the Audit Committee with pre-approval policies in place.

Insider Trading and Section 16 Compliance

  • The funds report that Board Members and officers complied with applicable Section 16(a) filing requirements during the last fiscal year and the prior fiscal year; no delinquent reports noted.

RED FLAGS

  • None identified in the proxy relating to related-party transactions, option repricing, tax gross-ups, or hedging/pledging by directors.